Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

Affiliations

¹ Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA. jcintolo-gonzalez@partners.org.
² Department of Biostatistics, Harvard University T H Chan School of Public Health, Boston, MA, USA.
³ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁶ Duke University Health Systems, Durham, NC, USA.

Published Erratum

Jessica A Cintolo-Gonzalez et al. Breast Cancer Res Treat. 2017 Aug.

. 2017 Aug;164(3):745.

doi: 10.1007/s10549-017-4349-7.

¹ Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA. jcintolo-gonzalez@partners.org.
² Department of Biostatistics, Harvard University T H Chan School of Public Health, Boston, MA, USA.
³ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁵ Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁶ Duke University Health Systems, Durham, NC, USA.

No abstract available

Erratum for

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Cintolo-Gonzalez JA, Braun D, Blackford AL, Mazzola E, Acar A, Plichta JK, Griffin M, Hughes KS. Cintolo-Gonzalez JA, et al. Breast Cancer Res Treat. 2017 Jul;164(2):263-284. doi: 10.1007/s10549-017-4247-z. Epub 2017 Apr 25. Breast Cancer Res Treat. 2017. PMID: 28444533 Review.